APO Research

APO RESEARCH · REPORT

EMOCAP

Selected research

Industry Growth & Trends

Global EMOCAP Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global EMOCAP market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the EMOCAP market include StretchSense, Noitom, Vicon, Cyber Glove Systems, Rokoko, MANUS, AiQ Synertial, Virtual Motion Labs and PhaseSpace, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global EMOCAP market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The EMOCAP market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global EMOCAP market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to EMOCAP.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global EMOCAP market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

EMOCAP Market by Company

StretchSense

Noitom

Vicon

Cyber Glove Systems

Rokoko

MANUS

AiQ Synertial

Virtual Motion Labs

PhaseSpace

VRTRIX

HaptX

Virdyn

Qualisys AB

Xsens Technologyes

Optitrack

Codamotion

PTI Phoenix Technologies

Noraxon USA

NTT Data

EMOCAP Segment by Type

Whole Boby

Part Boby

EMOCAP Segment by Application

Scientific Research

Entertainment

Medical

Other

EMOCAP Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EMOCAP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EMOCAP and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EMOCAP.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of EMOCAP companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global EMOCAP Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global EMOCAP Market Size by Region (2021-2026) & (US$ Million) Table 3. Global EMOCAP Market Share by Region (2021-2026) Table 4. Global EMOCAP Market Size by Region (2027-2032) & (US$ Million) Table 5. Global EMOCAP Market Share by Region (2027-2032) Table 6. Global EMOCAP Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global EMOCAP Market Size by Type (2021-2026) & (US$ Million) Table 8. Global EMOCAP Market Size Share by Type (2021-2026) Table 9. Global EMOCAP Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global EMOCAP Market Size Share Forecasted by Type (2027-2032) Table 11. North America EMOCAP Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America EMOCAP Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe EMOCAP Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe EMOCAP Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific EMOCAP Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific EMOCAP Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America EMOCAP Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America EMOCAP Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa EMOCAP Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa EMOCAP Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global EMOCAP Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global EMOCAP Market Size by Application (2021-2026) & (US$ Million) Table 23. Global EMOCAP Market Size Share by Application (2021-2026) Table 24. Global EMOCAP Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global EMOCAP Market Size Share Forecasted by Application (2027-2032) Table 26. North America EMOCAP Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America EMOCAP Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe EMOCAP Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe EMOCAP Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific EMOCAP Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific EMOCAP Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America EMOCAP Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America EMOCAP Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa EMOCAP Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa EMOCAP Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. EMOCAP Industry Trends Table 37. EMOCAP Industry Drivers Table 38. EMOCAP Industry Opportunities and Challenges Table 39. EMOCAP Industry Restraints Table 40. Global EMOCAP Revenue by Company (US$ Million) & (2021-2026) Table 41. Global EMOCAP Revenue Market Share by Company (2021-2026) Table 42. Global EMOCAP Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global EMOCAP Key Company Headquarters & Area Served Table 44. Global EMOCAP Company, Product Type & Application Table 45. Global EMOCAP Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global EMOCAP by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. StretchSense Company Information Table 49. StretchSense Business Overview Table 50. StretchSense EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. StretchSense EMOCAP Product Portfolio Table 52. StretchSense Recent Development Table 53. Noitom Company Information Table 54. Noitom Business Overview Table 55. Noitom EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Noitom EMOCAP Product Portfolio Table 57. Noitom Recent Development Table 58. Vicon Company Information Table 59. Vicon Business Overview Table 60. Vicon EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Vicon EMOCAP Product Portfolio Table 62. Vicon Recent Development Table 63. Cyber Glove Systems Company Information Table 64. Cyber Glove Systems Business Overview Table 65. Cyber Glove Systems EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Cyber Glove Systems EMOCAP Product Portfolio Table 67. Cyber Glove Systems Recent Development Table 68. Rokoko Company Information Table 69. Rokoko Business Overview Table 70. Rokoko EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Rokoko EMOCAP Product Portfolio Table 72. Rokoko Recent Development Table 73. MANUS Company Information Table 74. MANUS Business Overview Table 75. MANUS EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. MANUS EMOCAP Product Portfolio Table 77. MANUS Recent Development Table 78. AiQ Synertial Company Information Table 79. AiQ Synertial Business Overview Table 80. AiQ Synertial EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. AiQ Synertial EMOCAP Product Portfolio Table 82. AiQ Synertial Recent Development Table 83. Virtual Motion Labs Company Information Table 84. Virtual Motion Labs Business Overview Table 85. Virtual Motion Labs EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Virtual Motion Labs EMOCAP Product Portfolio Table 87. Virtual Motion Labs Recent Development Table 88. PhaseSpace Company Information Table 89. PhaseSpace Business Overview Table 90. PhaseSpace EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. PhaseSpace EMOCAP Product Portfolio Table 92. PhaseSpace Recent Development Table 93. VRTRIX Company Information Table 94. VRTRIX Business Overview Table 95. VRTRIX EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. VRTRIX EMOCAP Product Portfolio Table 97. VRTRIX Recent Development Table 98. HaptX Company Information Table 99. HaptX Business Overview Table 100. HaptX EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. HaptX EMOCAP Product Portfolio Table 102. HaptX Recent Development Table 103. Virdyn Company Information Table 104. Virdyn Business Overview Table 105. Virdyn EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Virdyn EMOCAP Product Portfolio Table 107. Virdyn Recent Development Table 108. Qualisys AB Company Information Table 109. Qualisys AB Business Overview Table 110. Qualisys AB EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Qualisys AB EMOCAP Product Portfolio Table 112. Qualisys AB Recent Development Table 113. Xsens Technologyes Company Information Table 114. Xsens Technologyes Business Overview Table 115. Xsens Technologyes EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Xsens Technologyes EMOCAP Product Portfolio Table 117. Xsens Technologyes Recent Development Table 118. Optitrack Company Information Table 119. Optitrack Business Overview Table 120. Optitrack EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Optitrack EMOCAP Product Portfolio Table 122. Optitrack Recent Development Table 123. Codamotion Company Information Table 124. Codamotion Business Overview Table 125. Codamotion EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Codamotion EMOCAP Product Portfolio Table 127. Codamotion Recent Development Table 128. PTI Phoenix Technologies Company Information Table 129. PTI Phoenix Technologies Business Overview Table 130. PTI Phoenix Technologies EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. PTI Phoenix Technologies EMOCAP Product Portfolio Table 132. PTI Phoenix Technologies Recent Development Table 133. Noraxon USA Company Information Table 134. Noraxon USA Business Overview Table 135. Noraxon USA EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Noraxon USA EMOCAP Product Portfolio Table 137. Noraxon USA Recent Development Table 138. NTT Data Company Information Table 139. NTT Data Business Overview Table 140. NTT Data EMOCAP Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. NTT Data EMOCAP Product Portfolio Table 142. NTT Data Recent Development Table 143. North America EMOCAP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America EMOCAP Market Size by Country (2021-2026) & (US$ Million) Table 145. North America EMOCAP Market Share by Country (2021-2026) Table 146. North America EMOCAP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America EMOCAP Market Share Forecast by Country (2027-2032) Table 148. Europe EMOCAP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe EMOCAP Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe EMOCAP Market Share by Country (2021-2026) Table 151. Europe EMOCAP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe EMOCAP Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific EMOCAP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific EMOCAP Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific EMOCAP Market Share by Country (2021-2026) Table 156. Asia-Pacific EMOCAP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific EMOCAP Market Share Forecast by Country (2027-2032) Table 158. Latin America EMOCAP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America EMOCAP Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America EMOCAP Market Share by Country (2021-2026) Table 161. Latin America EMOCAP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America EMOCAP Market Share Forecast by Country (2027-2032) Table 163. Middle East & Africa EMOCAP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East & Africa EMOCAP Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East & Africa EMOCAP Market Share by Country (2021-2026) Table 166. Middle East & Africa EMOCAP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East & Africa EMOCAP Market Share Forecast by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. EMOCAP Product Image Figure 3. Global EMOCAP Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global EMOCAP Market Size (2021-2032) & (US$ Million) Figure 5. Global EMOCAP Market Share by Region: 2025 VS 2032 Figure 6. Global EMOCAP Market Share by Region (2021-2032) Figure 7. North America EMOCAP Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe EMOCAP Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific EMOCAP Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America EMOCAP Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa EMOCAP Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Whole Boby Image Figure 13. Global Whole Boby Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Part Boby Image Figure 15. Global Part Boby Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global EMOCAP Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global EMOCAP Market Share by Type 2025 VS 2032 Figure 18. North America EMOCAP Market Size Share by Type (2021-2032) Figure 19. Europe EMOCAP Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific EMOCAP Market Size Share by Type (2021-2032) Figure 21. Latin America EMOCAP Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa EMOCAP Market Size Share by Type (2021-2032) Figure 23. Scientific Research Image Figure 24. Global Scientific Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Entertainment Image Figure 26. Global Entertainment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Medical Image Figure 28. Global Medical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global EMOCAP Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global EMOCAP Market Share by Application 2025 VS 2032 Figure 33. North America EMOCAP Market Size Share by Application (2021-2032) Figure 34. Europe EMOCAP Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific EMOCAP Market Size Share by Application (2021-2032) Figure 36. Latin America EMOCAP Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa EMOCAP Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 EMOCAP Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America EMOCAP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America EMOCAP Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America EMOCAP Market Share by Country (2021-2032) Figure 43. Europe EMOCAP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe EMOCAP Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe EMOCAP Market Share by Country (2021-2032) Figure 46. Asia-Pacific EMOCAP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific EMOCAP Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific EMOCAP Market Share by Country (2021-2032) Figure 49. Latin America EMOCAP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America EMOCAP Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America EMOCAP Market Share by Country (2021-2032) Figure 52. Middle East & Africa EMOCAP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa EMOCAP Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa EMOCAP Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Whole Boby
  • Part Boby
Applications
  • Scientific Research
  • Entertainment
  • Medical
  • Other
Companies covered
  • StretchSense
  • Noitom
  • Vicon
  • Cyber Glove Systems
  • Rokoko
  • MANUS
  • AiQ Synertial
  • Virtual Motion Labs
  • PhaseSpace
  • VRTRIX
  • HaptX
  • Virdyn
  • Qualisys AB
  • Xsens Technologyes
  • Optitrack
  • Codamotion
  • PTI Phoenix Technologies
  • Noraxon USA
  • NTT Data

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global EMOCAP Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global EMOCAP Market Size by Region (2021-2032)
  5. 1.4.1 Global EMOCAP Market Size by Region (2021-2026)
  6. 1.4.2 Global EMOCAP Market Size by Region (2027-2032)
  7. 1.5 Key Regions EMOCAP Market Size (2021-2032)
  8. 1.5.1 North America EMOCAP Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe EMOCAP Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific EMOCAP Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America EMOCAP Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa EMOCAP Market Size Growth Rate (2021-2032)
2 EMOCAP Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Whole Boby
  3. 2.1.2 Part Boby
  4. 2.2 Global EMOCAP Market Size by Type
  5. 2.2.1 Global EMOCAP Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global EMOCAP Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global EMOCAP Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global EMOCAP Market Size by Regions
  9. 2.3.1 North America EMOCAP Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe EMOCAP Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific EMOCAP Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America EMOCAP Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa EMOCAP Market Size Breakdown by Type (2021-2026)
3 EMOCAP Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Scientific Research
  3. 3.1.2 Entertainment
  4. 3.1.3 Medical
  5. 3.1.4 Other
  6. 3.2 Global EMOCAP Market Size by Application
  7. 3.2.1 Global EMOCAP Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global EMOCAP Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global EMOCAP Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global EMOCAP Market Size by Regions
  11. 3.3.1 North America EMOCAP Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe EMOCAP Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific EMOCAP Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America EMOCAP Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa EMOCAP Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 EMOCAP Industry Trends
  2. 4.2 EMOCAP Industry Drivers
  3. 4.3 EMOCAP Industry Opportunities and Challenges
  4. 4.4 EMOCAP Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by EMOCAP Revenue (2021-2026)
  2. 5.2 Global EMOCAP Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global EMOCAP Key Company Headquarters & Area Served
  4. 5.4 Global EMOCAP Company, Product Type & Application
  5. 5.5 Global EMOCAP Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global EMOCAP Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 EMOCAP Players Market Share by Revenue in 2025
  9. 5.6.3 2025 EMOCAP Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 StretchSense
  2. 6.1.1 StretchSense Company Information
  3. 6.1.2 StretchSense Business Overview
  4. 6.1.3 StretchSense EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 StretchSense EMOCAP Product Portfolio
  6. 6.1.5 StretchSense Recent Developments
  7. 6.2 Noitom
  8. 6.2.1 Noitom Company Information
  9. 6.2.2 Noitom Business Overview
  10. 6.2.3 Noitom EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Noitom EMOCAP Product Portfolio
  12. 6.2.5 Noitom Recent Developments
  13. 6.3 Vicon
  14. 6.3.1 Vicon Company Information
  15. 6.3.2 Vicon Business Overview
  16. 6.3.3 Vicon EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Vicon EMOCAP Product Portfolio
  18. 6.3.5 Vicon Recent Developments
  19. 6.4 Cyber Glove Systems
  20. 6.4.1 Cyber Glove Systems Company Information
  21. 6.4.2 Cyber Glove Systems Business Overview
  22. 6.4.3 Cyber Glove Systems EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Cyber Glove Systems EMOCAP Product Portfolio
  24. 6.4.5 Cyber Glove Systems Recent Developments
  25. 6.5 Rokoko
  26. 6.5.1 Rokoko Company Information
  27. 6.5.2 Rokoko Business Overview
  28. 6.5.3 Rokoko EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Rokoko EMOCAP Product Portfolio
  30. 6.5.5 Rokoko Recent Developments
  31. 6.6 MANUS
  32. 6.6.1 MANUS Company Information
  33. 6.6.2 MANUS Business Overview
  34. 6.6.3 MANUS EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 MANUS EMOCAP Product Portfolio
  36. 6.6.5 MANUS Recent Developments
  37. 6.7 AiQ Synertial
  38. 6.7.1 AiQ Synertial Company Information
  39. 6.7.2 AiQ Synertial Business Overview
  40. 6.7.3 AiQ Synertial EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 AiQ Synertial EMOCAP Product Portfolio
  42. 6.7.5 AiQ Synertial Recent Developments
  43. 6.8 Virtual Motion Labs
  44. 6.8.1 Virtual Motion Labs Company Information
  45. 6.8.2 Virtual Motion Labs Business Overview
  46. 6.8.3 Virtual Motion Labs EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Virtual Motion Labs EMOCAP Product Portfolio
  48. 6.8.5 Virtual Motion Labs Recent Developments
  49. 6.9 PhaseSpace
  50. 6.9.1 PhaseSpace Company Information
  51. 6.9.2 PhaseSpace Business Overview
  52. 6.9.3 PhaseSpace EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 PhaseSpace EMOCAP Product Portfolio
  54. 6.9.5 PhaseSpace Recent Developments
  55. 6.10 VRTRIX
  56. 6.10.1 VRTRIX Company Information
  57. 6.10.2 VRTRIX Business Overview
  58. 6.10.3 VRTRIX EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 VRTRIX EMOCAP Product Portfolio
  60. 6.10.5 VRTRIX Recent Developments
  61. 6.11 HaptX
  62. 6.11.1 HaptX Company Information
  63. 6.11.2 HaptX Business Overview
  64. 6.11.3 HaptX EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 HaptX EMOCAP Product Portfolio
  66. 6.11.5 HaptX Recent Developments
  67. 6.12 Virdyn
  68. 6.12.1 Virdyn Company Information
  69. 6.12.2 Virdyn Business Overview
  70. 6.12.3 Virdyn EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Virdyn EMOCAP Product Portfolio
  72. 6.12.5 Virdyn Recent Developments
  73. 6.13 Qualisys AB
  74. 6.13.1 Qualisys AB Company Information
  75. 6.13.2 Qualisys AB Business Overview
  76. 6.13.3 Qualisys AB EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Qualisys AB EMOCAP Product Portfolio
  78. 6.13.5 Qualisys AB Recent Developments
  79. 6.14 Xsens Technologyes
  80. 6.14.1 Xsens Technologyes Company Information
  81. 6.14.2 Xsens Technologyes Business Overview
  82. 6.14.3 Xsens Technologyes EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Xsens Technologyes EMOCAP Product Portfolio
  84. 6.14.5 Xsens Technologyes Recent Developments
  85. 6.15 Optitrack
  86. 6.15.1 Optitrack Company Information
  87. 6.15.2 Optitrack Business Overview
  88. 6.15.3 Optitrack EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Optitrack EMOCAP Product Portfolio
  90. 6.15.5 Optitrack Recent Developments
  91. 6.16 Codamotion
  92. 6.16.1 Codamotion Company Information
  93. 6.16.2 Codamotion Business Overview
  94. 6.16.3 Codamotion EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Codamotion EMOCAP Product Portfolio
  96. 6.16.5 Codamotion Recent Developments
  97. 6.17 PTI Phoenix Technologies
  98. 6.17.1 PTI Phoenix Technologies Company Information
  99. 6.17.2 PTI Phoenix Technologies Business Overview
  100. 6.17.3 PTI Phoenix Technologies EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 PTI Phoenix Technologies EMOCAP Product Portfolio
  102. 6.17.5 PTI Phoenix Technologies Recent Developments
  103. 6.18 Noraxon USA
  104. 6.18.1 Noraxon USA Company Information
  105. 6.18.2 Noraxon USA Business Overview
  106. 6.18.3 Noraxon USA EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Noraxon USA EMOCAP Product Portfolio
  108. 6.18.5 Noraxon USA Recent Developments
  109. 6.19 NTT Data
  110. 6.19.1 NTT Data Company Information
  111. 6.19.2 NTT Data Business Overview
  112. 6.19.3 NTT Data EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 NTT Data EMOCAP Product Portfolio
  114. 6.19.5 NTT Data Recent Developments
7 North America
  1. 7.1 North America EMOCAP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America EMOCAP Market Size by Country (2021-2026)
  3. 7.3 North America EMOCAP Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe EMOCAP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe EMOCAP Market Size by Country (2021-2026)
  3. 8.3 Europe EMOCAP Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific EMOCAP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific EMOCAP Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific EMOCAP Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America EMOCAP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America EMOCAP Market Size by Country (2021-2026)
  3. 10.3 South America EMOCAP Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa EMOCAP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa EMOCAP Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa EMOCAP Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research